Skip to main content

Table 3 Completion rates of adjuvant chemotherapy

From: Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience

 

UFT

(n = 37)

S-1

(n = 49)

p value#

Total number of completions

27

(72.9)

36

(73.5)

0.96

 Dose reduction or schedule modification

10

(37.0)

19

(52.8)

0.21

Total number of discontinuations

10

(27.0)

13

(26.5)

0.96

 Adverse event

3

(30.0)

3

(23.1)

0.10

 Disease progression

4

(40.0)

10

(76.9)

 Drop out

3

(30.0)

0

(0)

  1. Data are number of patients (%)
  2. UFT tegafur-uracil, S-1 tegafur-gimeracil-oteracil
  3. #Comparison of completion rates between the UFT and S-1 groups